A multi-fluid injector system and methods of operation thereof are presented. One embodiment of such a fluid injector system includes an automatic refill procedure for a fluid injector system comprising a fluid injector and an operably engaged syringe. The procedure includes the step of determining, using an electronic control device operably controlling the fluid injector system, whether a fluid injection procedure involving the syringe is impending. If the electronic control device determines that the fluid injection procedure is not impending, such that the automatic refill will not interfere with the fluid injection procedure, an automatic refill of the syringe is initiated.

A retrograde disposable intravenous (IV) set is disclosed. The IV set includes a diverter housing between upper and lower portions of a fluid line, the diverter housing including a lower end and an upper end extending away from the lower end and the fluid line to a syringe port located in the upper end, and a diverter member within the diverter housing and configured to move within the diverter housing from a first position, at which a first opening through the diverter member forms a first fluid pathway between the upper portion and the lower portion of the fluid line, to a second position, at which the first fluid pathway is blocked and a second fluid pathway is formed between the upper portion of the fluid line and a syringe port. Retrograde infusion may occur when the diverter member is in the second position.

A patient specific therapeutic composition provided in a single dose container, the total volume of which may be administered to a patient in a single treatment session. The composition includes a monoclonal antibody having a labeled fraction and an unlabeled fraction, and a pharmaceutically acceptable carrier. The label may be any of a radioisotope or a drug such as a chemotherapeutic or cytotoxic agent. The amount of the monoclonal antibody and any conjugated label molecule may depend on at least one patient specific parameter selected from a patient weight, a patient age, a patient height, a patient gender, a patient medical condition, and a patient medical history. Methods of administration, production, and articles of manufacture comprising the patient specific therapeutic composition are also disclosed.

A flush device may be used to flush a catheter system. The flush device may include a housing, a proximal connector coupled to the housing, and a distal connector coupled to the housing. The flush device may include a first conduit disposed within the housing and extending between the proximal connector and the distal connector. The flush device may include a second conduit disposed within the housing and in fluid communication with the first conduit. The flush device may include a fluid reservoir, which may be disposed within the housing of the flush device. The flush device may include a pump that pumps fluid from the fluid reservoir, through the second conduit, and into the first conduit. The device may include a one-way valve, which may prevent fluid from flowing beyond the one-way valve toward the fluid reservoir.

Dual chamber drip controlling device for intravenous infusion sets enabling spontaneous flushing and a method for flushing a dual chamber drip controlling device, wherein said dual chamber comprises a flushing chamber configured as a closed compartment, said flushing chamber being tillable with flushing fluid; an administration chamber configured as a gravity based drip chamber with an inlet and outlet; and two conduits, namely conduit A and conduit B connecting the administration chamber to the flushing chamber, wherein each fluid conduit is provided with restriction means for restricting passage from the flushing chamber to the administration chamber, said restriction means being openable so as to render the administration chamber flushable.

A patency checking system, may include a fluid path to be coupled to an intravenous (IV) device at a distal end of the fluid path; a patency port formed along a length of the fluid path; and a plunger fluidically coupled to the fluid path at the patency port to selectively draw blood into the fluid path to confirm patency of the fluid path.

A fluid management system for moving bodily fluid accumulated due to ascites, pleural effusion or pericardial effusion is provided including an implantable pump coupled to an inflow catheter, an outflow catheter, and optionally an anti-clog catheter. The fluid management system facilitates removal of fluid from a body region, such as the peritoneum, pleural cavity or pericardial sac, where drainage is desired to another body region, such as the urinary bladder or the peritoneal cavity. The system includes clog resistant mechanisms such as clog resistant catheters and/or programmed routines for cycling fluid through inlet catheters in predetermined time intervals and/or responsive to sensed conditions to minimize the risk that inlet catheters become clogged due to, for example, tissue ingrowth and/or solid objects within accumulated fluid.

A treatment method is disclosed capable of reducing the burden on a patient and enhancing the effect of killing tumor cells. A treatment method for killing a tumor cell, the method including inserting a catheter into a main artery of an organ having the tumor cell, administering an antibody-photosensitive substance into a vein before the inserting of the catheter, inserting an optical fiber into the catheter, reducing an influence of blood in the artery on a near-infrared ray, irradiating at least one of a tumor, the vicinity of the tumor, or a regional lymph node with a first near-infrared ray by the optical fiber, and irradiating an antibody-photosensitive substance bound to a tumor cell membrane in the tumor cell with a second near-infrared ray having a shorter wavelength than that of the first near-infrared ray.

Disclosed is a system for injecting a radioactive product to a patient, wherein the system includes: a first syringe containing the radioactive product, whose plunger cooperates with an injection mass, acting by gravity, associated with deactivatable holding element; a mobile stop arranged to constitute an end-of-travel stop for the retraction of the plunger, as a function of the volume of radioactive product to be injected to the patient; a second syringe containing a rinsing product, whose plunger cooperates with a rinsing mass, acting by gravity, associated with deactivatable holding element; a trigger control element for triggering the injection of the radioactive product to the patient; and a management element including a unit for displacing the mobile stop structure as a function of the prescribed activity to be injected to the patient, and a unit for controlling the deactivatable holding element of the masses.

Disclosed is a fluid delivery device including a fluid reservoir and a transcutaneous access tool fluidly coupled to the fluid reservoir, wherein the transcutaneous access tool includes a needle or a trocar. The fluid delivery device may further include a transcutaneous access tool insertion mechanism for deploying the transcutaneous access tool, wherein the insertion mechanism is configured to insert and retract the needle/trocar in a single, uninterrupted motion.